Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment.
Vysotskaia VS, Hogan GJ, Gould GM, Wang X, Robertson AD, Haas KR, Theilmann MR, Spurka L, Grauman PV, Lai HH, Jeon D, Haliburton G, Leggett M, Chu CS, Iori K, Maguire JR, Ready K, Evans EA, Kang HP, Haque IS.
Vysotskaia VS, et al. Among authors: hogan gj.
PeerJ. 2017 Feb 23;5:e3046. doi: 10.7717/peerj.3046. eCollection 2017.
PeerJ. 2017.
PMID: 28243543
Free PMC article.